Cargando…

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province

PURPOSE: This study was designed to identify the phenotypic and genotypic characteristics of pyrazinamide (PZA) resistance among multidrug-resistant Mycobacterium tuberculosis (MDR-TB) from Henan and to evaluate the efficacy of pncA, rpsA, and panD mutations in predicting PZA resistance. MATERIALS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jie, Su, Ruyue, Zheng, Danwei, Zhu, Yankun, Ma, Xiaoguang, Wang, Shaohua, Li, Hui, Sun, Dingyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445508/ https://www.ncbi.nlm.nih.gov/pubmed/32903869 http://dx.doi.org/10.2147/IDR.S260161

Ejemplares similares

Role of MIRU-VNTR and spoligotyping in assessing the genetic diversity of Mycobacterium tuberculosis in Henan Province, China
por: Shi, Jie, et al.
Publicado: (2018)

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
por: Shi, Dawei, et al.
Publicado: (2022)

Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China
por: Shi, Dawei, et al.
Publicado: (2011)

Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
por: Rahman, Arfatur, et al.
Publicado: (2017)

Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China
por: Hameed, HM Adnan, et al.
Publicado: (2020)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
por: Xia, Hui, et al.
Publicado: (2020)

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001)

Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
por: Che, Yang, et al.
Publicado: (2021)

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates
por: Huy, Nguyen Quang, et al.
Publicado: (2017)

Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
por: Pang, Yu, et al.
Publicado: (2017)

Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study
por: Zhang, Chunxiao, et al.
Publicado: (2016)

Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand
por: Jonmalung, Jirarut, et al.
Publicado: (2010)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
por: Miotto, Paolo, et al.
Publicado: (2014)

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2013)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
por: Kahbazi, Manijeh, et al.
Publicado: (2018)

Correction: Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand
por: Jonmalung, Jirarut, et al.
Publicado: (2010)

Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China
por: Li, Wei-Bin, et al.
Publicado: (2015)

PncAgene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis
por: Untiveros, Katherine Lozano, et al.
Publicado: (2014)

Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosis
por: Havlicek, Juliane, et al.
Publicado: (2019)

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
por: Sengstake, Sarah, et al.
Publicado: (2017)

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021)

Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
por: khan, Muhammad Tahir, et al.
Publicado: (2019)

Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance
por: Shrestha, Dipti, et al.
Publicado: (2022)

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide
por: Petrella, Stéphanie, et al.
Publicado: (2011)

Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California
por: Budzik, Jonathan M., et al.
Publicado: (2014)

Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
por: Whitfield, Michael G., et al.
Publicado: (2022)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis
por: Yee, Michelle, et al.
Publicado: (2017)

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance
por: Sheen, Patricia, et al.
Publicado: (2017)

Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase
por: Sheik Amamuddy, Olivier, et al.
Publicado: (2020)

Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
por: Florentini, Edgar A., et al.
Publicado: (2020)

Knockdown resistance of Anopheles sinensis in Henan province, China
por: Zhang, Hong-wei, et al.
Publicado: (2015)

Molecular Epidemiological Study of Pyrazinamide-Resistance in Clinical Isolates of Mycobacterium tuberculosis from South India
por: Muthaiah, Muthuraj, et al.
Publicado: (2010)

Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
por: Florentini, Edgar A., et al.
Publicado: (2021)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
por: Nasiri, M.J., et al.
Publicado: (2021)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
por: Manca, Claudia, et al.
Publicado: (2013)

Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant Mycobacterium tuberculosis in Zambia
por: Bwalya, Precious, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69ai2ogusal117157unoiodcth